Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States.

Salem, Ahmed; La, Elizabeth M; Curran, Desmond; Patterson, Brandon J; Carrico, Justin; Lorenc, Stéphane; Hicks, Katherine A; Poston, Sara; Carpenter, Christopher F

Salem, Ahmed; La, Elizabeth M; Curran, Desmond; Patterson, Brandon J; Carrico, Justin; Lorenc, Stéphane; Hicks, Katherine A; Poston, Sara; Carpenter, Christopher F.

Afiliación

Salem A; GSK, Avenue Pascal 2/4-6, 1300, Wavre, Belgium. salem.x.ahmedehab@gsk.com.
La EM; GSK, Philadelphia, PA, USA.
Curran D; GSK, Avenue Pascal 2/4-6, 1300, Wavre, Belgium.
Patterson BJ; GSK, Philadelphia, PA, USA.
Carrico J; Janssen Global Services, Raritan, NJ, USA.
Lorenc S; RTI Health Solutions, Research Triangle Park, NC, USA.
Hicks KA; GSK, Avenue Pascal 2/4-6, 1300, Wavre, Belgium.
Poston S; RTI Health Solutions, Research Triangle Park, NC, USA.
Carpenter CF; GSK, Philadelphia, PA, USA.

Pharmacoecon Open ; 7(6): 975-985, 2023 Nov.

Article en En | MEDLINE | ID: mdl-37917310

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmacoecon Open Año: 2023 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google